0001209191-23-012789.txt : 20230224 0001209191-23-012789.hdr.sgml : 20230224 20230224170859 ACCESSION NUMBER: 0001209191-23-012789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230223 FILED AS OF DATE: 20230224 DATE AS OF CHANGE: 20230224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olefson Jonathan CENTRAL INDEX KEY: 0001673025 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 23668550 MAIL ADDRESS: STREET 1: C/O SYNEOS HEALTH, INC. STREET 2: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-23 0 0001610950 Syneos Health, Inc. SYNH 0001673025 Olefson Jonathan C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 0 1 0 0 General Counsel & Corp Secty Class A Common Stock 2023-02-23 4 A 0 2609 0.00 A 64713 D Class A Common Stock 2023-02-23 4 A 0 891 0.00 A 65604 D Class A Common Stock 2023-02-23 4 A 0 602 0.00 A 66206 D Class A Common Stock 2023-02-23 4 F 0 2001 38.25 D 64205 D Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022. Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full on the date on which the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment. Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2024, subject to continued employment. /s/ Sara Epstein, Attorney-in-Fact 2023-02-24